Financhill
Back

Dexterra Group Quote, Financials, Valuation and Earnings

Dexterra Group Price Quote

$6.56
-0.03 (-0.46%)
(Updated: November 14, 2024 at 1:25 PM ET)

Dexterra Group Key Stats

Buy
74
Dexterra Group (DXT.TO) is a Buy

Day range:
$6.40 - $6.59
52-week range:
$5.13 - $6.93
Dividend yield:
5.39%
P/E ratio:
15.85
P/S ratio:
0.36
P/B ratio:
1.47%

Volume:
30.8K
Avg. volume:
28.7K
1-year change:
14.61%
Market cap:
$414.9M
Revenue:
$1.1B
EPS:
$0.2

How Much Does Dexterra Group Make?

Is Dexterra Group Growing As A Company?

  • What Is Dexterra Group's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.01%
  • What Is Dexterra Group's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.43%

Dexterra Group Stock Price Performance

  • Did Dexterra Group Stock Go Up Last Month?
    Dexterra Group share price went down by -1.64% last month
  • Did DXT.TO's Share Price Rise Over The Last Year?
    DXT.TO share price rose by 14.61% over the past 1 year

What Is Dexterra Group 52-Week High & Low?

Dexterra Group Price To Free Cash Flow

Is It Risky To Buy Dexterra Group?

Data Unavailable

Is Dexterra Group Cash Flow Positive?

  • What Is DXT.TO Cash Flow From Operations?
    Cash flow from operations (TTM) is $68.7M
  • What Is Dexterra Group’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$82M
  • What Is Dexterra Group’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $13.3M

Dexterra Group Return On Invested Capital

  • Is Management Doing A Good Job?
    DXT.TO return on invested capital is 3.15%
  • What Is Dexterra Group Return On Assets?
    ROA measures how assets are converting to revenues and is 2.02%
  • What Is DXT.TO Return On Equity?
    ROE is a measure of profitability and is 4.48%

Dexterra Group Earnings Date & Stock Price

Dexterra Group Competitors

  • Who Are Dexterra Group's Competitors?
    Below is a list of companies who compete with Dexterra Group or are related in some way:
    • Bactech Environmental Corp (BAC.CX)
    • Doman Building Materials Group Ltd (DBM.TO)
    • Beyond Medical Technologies Inc (DOCT.CX)
    • Exchange Income Corp (EIF.TO)
    • Mullen Group Ltd (MTL.TO)

Dexterra Group Dividend Yield

Dexterra Group Analyst Estimates

YoY Growth Past Surprise
EPS: -42.86% 0%
Revenue: 1.47% -0.49%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 9.03
Upside from Last Price: 37.08%

Major Shareholders

  • How many DXT.TO shares are owned by institutional investors?
    5.7M DXT.TO shares are owned by institutional investors
  • How many DXT.TO shares are owned by insiders?
    0 DXT.TO shares are owned by insiders